Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
82
PharmaCompass offers a list of Imipenem + Cilastatin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Imipenem + Cilastatin manufacturer or Imipenem + Cilastatin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Imipenem + Cilastatin manufacturer or Imipenem + Cilastatin supplier.
PharmaCompass also assists you with knowing the Imipenem + Cilastatin API Price utilized in the formulation of products. Imipenem + Cilastatin API Price is not always fixed or binding as the Imipenem + Cilastatin Price is obtained through a variety of data sources. The Imipenem + Cilastatin Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Imipenem Cilastatin Sodium manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Imipenem Cilastatin Sodium, including repackagers and relabelers. The FDA regulates Imipenem Cilastatin Sodium manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Imipenem Cilastatin Sodium API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Imipenem Cilastatin Sodium manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Imipenem Cilastatin Sodium supplier is an individual or a company that provides Imipenem Cilastatin Sodium active pharmaceutical ingredient (API) or Imipenem Cilastatin Sodium finished formulations upon request. The Imipenem Cilastatin Sodium suppliers may include Imipenem Cilastatin Sodium API manufacturers, exporters, distributors and traders.
click here to find a list of Imipenem Cilastatin Sodium suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Imipenem Cilastatin Sodium Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Imipenem Cilastatin Sodium GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Imipenem Cilastatin Sodium GMP manufacturer or Imipenem Cilastatin Sodium GMP API supplier for your needs.
A Imipenem Cilastatin Sodium CoA (Certificate of Analysis) is a formal document that attests to Imipenem Cilastatin Sodium's compliance with Imipenem Cilastatin Sodium specifications and serves as a tool for batch-level quality control.
Imipenem Cilastatin Sodium CoA mostly includes findings from lab analyses of a specific batch. For each Imipenem Cilastatin Sodium CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Imipenem Cilastatin Sodium may be tested according to a variety of international standards, such as European Pharmacopoeia (Imipenem Cilastatin Sodium EP), Imipenem Cilastatin Sodium JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Imipenem Cilastatin Sodium USP).
